ask our doctors

Cardiogenic Shock

Get the facts on Cardiogenic Shock treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Cardiogenic Shock prevention, screening, research, statistics and other Cardiogenic Shock related topics. We answer all your qestions about Cardiogenic Shock.

Question: What is the difference between Heart Faliure and Cardiogenic Shock? By definition, shock is a state in which the perfusion is not adequate to maintain the metabolic needs of the bodys cells, if the underlying disease affects the myocardium then the condition is called cardiogenic shock since it is cardiogenic in origin. Heart faliure is defined in my USMLE book as "inability of the heart to maintain an adequate output to meet the body's metabolic needs" What is the difference between the two?

Answer: The main thing would be the timeframe in which they occur. Heart failure is usually over a long period of time, like if someone has uncontrolled high blood pressure, their heart is working hard to push the blood around the body. After years of this, it becomes weaker and weaker. This can happen from fluid overload, high blood pressure, drugs, and many other things. Cardiogenic shock is something that happens over a short period of time. The heart is put into shock by some sort of trauma, like from an arrhythmia or heart attack. Another big difference is some of their causes. Just look up each in wikipedia and you'll find a lot of info on them.


Cardiogenic Shock News

MI-shock proposal is cold comfort: Hypothermia might boost survival

TheHeart.Org
Boston, MA - Therapeutic hypothermia can help preserve the brain during cardiac arrest, so maybe it could protect organs throughout the body in other conditions that threaten their blood supply?such as cardiogenic shock.
 

New ACCF/AHA/SCAI Guidelines With Increased Recommendations for the Use of ...

MarketWatch (press release)
Class I: Cardiogenic Shock "A hemodynamic support device is recommended for patients with cardiogenic shock after STEMI who do not quickly stabilize with pharmacological therapy."(Level of Evidence B) Class IIb: Adjunctive Therapeutic Devices: ...
 

Deaths/causes | PUBLIC RECORDS | Nov. 30 to Jan. 3

Evansville Courier & Press
29; acute cardiogenic shock secondary to protamine reaction after coronary artery bypass surgery Badillo, Valentin; 37, Seebree, Ky., Dec. 27; brain death, intracranial hemorrhage Balding, Naomi Star; 100, Evansville, Dec. 23; failure to thrive, ...
 

Abiomed (ABMD) Given "Buy" Rating by Wunderlich Analysts

LocalizedUSA
... cardiologists and/or in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophelactically during high risk angioplasty procedures or who are in pre- shock, shock or profound cardiogenic shock.
 

FDA approves Novartis drug Gleevec® label recommending extending treatment to ...

PR Newswire (press release)
In patients with hypereosinophilic syndrome (a condition with increased eosinophils, which are a type of white blood cell) and heart involvement, cases of heart disease (cardiogenic shock/left ventricular dysfunction) have been associated with the ...
 

Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN(R)

MarketWatch (press release)
These fatalities were associated with hypoxia, pulmonary infiltrates, acute respiratory distress syndrome, myocardial infarction, ventricular fibrillation, or cardiogenic shock. Most (80%) fatalities occurred with the first rituximab infusion.
 

Live Each Day to the Fullest

Patch.com
4 and 24 hours later he was in the Cardiac Care Unit at Kennestone Hospital with cardiogenic shock?a life threatening heart condition. He miraculously survived the event and even regained full cardiac function, which was not expected. But a week later ...
 

Vasomedical Recorded Record Net Income of $2.47 Million for the Second Quarter ...

MarketWatch (press release)
EECP(R) therapy is a non-invasive, outpatient therapy for the treatment of cardiovascular diseases and is currently indicated for use in cases of angina, cardiogenic shock, acute myocardial infarction and congestive heart failure.
 

ZEVALIN Plus High Dose Chemotherapy (Z-BEAM) Highly Effective in Aggressive ...

MarketWatch (press release)
These fatalities were associated with hypoxia, pulmonary infiltrates, acute respiratory distress syndrome, myocardial infarction, ventricular fibrillation, or cardiogenic shock. Most (80%) fatalities occurred with the first rituximab infusion.
 

Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN®

Business Wire (press release)
These fatalities were associated with hypoxia, pulmonary infiltrates, acute respiratory distress syndrome, myocardial infarction, ventricular fibrillation, or cardiogenic shock. Most (80%) fatalities occurred with the first rituximab infusion.